Skip to content

Use of New Technology in Imaging of Cancer.

Applications of Subtraction Imaging in Non-Vascular Magnetic Resonance Imaging.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/12/022474
Enrollment
21
Registered
2019-12-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D289- Benign neoplasm of female genitalorgan, unspecified Health Condition 2: D279- Benign neoplasm of unspecified ovary Health Condition 3: N281- Cyst of kidney, acquired Health Condition 4: C800- Disseminated malignant neoplasm, unspecified Health Condition 5: D180- Hemangioma Health Condition 6: C220- Liver cell carcinoma Health Condition 7: C719- Malignant neoplasm of brain, unspecified Health Condition 8: C716- Malignant neoplasm of cerebellum Health Condition 9: C693- M

Interventions

None listed

Sponsors

Kasturba Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Hyperintense lesion in pre-contrast T1WI sequence. Patients suspected of avascular necrosis.

Exclusion criteria

Exclusion criteria: 1. When all technical parameters (TR/TE/flip angle/slice thickness/matrix/zero interpolation factor) are not constant from unenhanced to the enhanced sequences. 2. Change in patient position during unenhanced and enhanced sequences. 3. Patient unable to maintain/reproduce a breath hold for sequences.

Design outcomes

Primary

MeasureTime frame
applications of subtraction imaging in non vascular magnetic resonance imaging will be exploredTimepoint: outcome will be achieved at the end of study.

Secondary

MeasureTime frame
not applicableTimepoint: not applicable

Countries

India

Contacts

Public ContactDr Rajagopal K V

Kasturba Medical College

tutejashaifali34@gmail.com9996004593

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026